Measuring the quality of journals and journal articles: The impact factor tells but a portion of the story

被引:79
作者
Favaloro, Emmanuel J. [1 ]
机构
[1] Westmead Hosp, ICPMR, Dept Haematol, SWAHS, Westmead, NSW 2145, Australia
关键词
impact factor; journal quality; review; commentary;
D O I
10.1055/s-2008-1066030
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Much emphasis has been placed on the impact factor, a measure of journal article citation rates used as a surrogate marker of both journal and article quality. There is little doubt that the impact factor is an important audit of journal article usage, as it in essence provides a measure of the level of peer attention being given to articles within journals and (by extrapolation) of the level of attention being given to the journal containing those articles. However, the impact factor has its limitations and only tells a very small fraction of the overall story regarding the utility of journals and the articles within them. In addition, the impact factor can be easily manipulated. The current article includes a brief review of the current and past uses and abuses of the impact factor and describes some of its strengths and limitations. In addition, a review of past publications, primarily from this journal, has been undertaken to help show the potential use of alternative measures of journal utility, such as Internet-based journal sessions and article downloads. The evaluation of previously published articles also helps serve to illustrate, by example, some of the limitations to the use of the impact factor as the sole determinant of a journal's "quality.".
引用
收藏
页码:7 / 25
页数:19
相关论文
共 90 条
[41]   Genetic testing for thrombophilia mutations [J].
Hertzberg, MS .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2005, 31 (01) :33-38
[42]   Hepatic veno-occlusive disease after hematopoietic stern cell transplantation: Review and update on the use of defibrotide [J].
Ho, Vincent T. ;
Linden, Erica ;
Revta, Carolyn ;
Richardson, Paul G. .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2007, 33 (04) :373-388
[43]   Periprocedural management of anticoagulation in patients on extended warfarin therapy [J].
Jafri, SM ;
Mehta, TP .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2004, 30 (06) :657-664
[44]   CIRCADIAN VARIATION IN PLATELET-FUNCTION IN HEALTHY-VOLUNTEERS [J].
JAFRI, SM ;
VANROLLINS, M ;
OZAWA, T ;
MAMMEN, EF ;
GOLDBERG, AD ;
GOLDSTEIN, S .
AMERICAN JOURNAL OF CARDIOLOGY, 1992, 69 (09) :951-954
[45]   Platelets: Physiology and biochemistry [J].
Jurk, K ;
Kehrel, BE .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2005, 31 (04) :381-392
[46]   Pathobiology of atherosclerosis - a brief review [J].
Kher, N ;
Marsh, JD .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2004, 30 (06) :665-672
[47]   Risk stratification of acute pulmonary embolism [J].
Kucher, Nils ;
Goldhaber, Samuel Z. .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2006, 32 (08) :838-847
[48]   Preclinical and clinical characteristics of rivaroxaban: A novel, oral, direct factor Xa inhibitor [J].
Laux, Volker ;
Perzborn, Elisabeth ;
Kubitza, Dagmar ;
Misselwitz, Frank .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2007, 33 (05) :515-523
[49]   Prevention of arthropathy in haemophilia - intensive on-demand treatment, UK perspective [J].
Lee, C. A. .
HAEMOPHILIA, 2008, 14 :11-15
[50]   Tissue factor in infection and severe inflammation [J].
Levi, M ;
van der Poll, T ;
ten Cate, H .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2006, 32 (01) :33-39